University of Auckland
18 papers found
C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: a genetic and pathologic study using banked human brain tissue
An anti-inflammatory role for C/EBPδ in human brain pericytes
Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS
Novel mutations support a role for Profilin 1 in the pathogenesis of ALS
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
Motor neurone disease: bringing New Zealand patients onto the world stage.
Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS.
Allele-Specific Knockdown of ALS-Associated Mutant TDP-43 in Neural Stem Cells Derived from Induced Pluripotent Stem Cells
Amyotrophic lateral sclerosis/motor neuron disease
Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species
Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic
ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules
Neuromuscular disease: new insights and avenues for therapy
The therapeutic potential of G-protein coupled receptors in Huntington's disease
Cannabinoid Receptor Signal Transduction Pathways
High throughput quantification of mutant huntingtin aggregates
Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal
Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathway.
Missing publications? Search for publications with a matching author name.